Armata Pharmaceuticals (ARMP) PT Raised to $9 at H.C. Wainwright

May 20, 2025 6:39 AM EDT Send to a Friend
H.C. Wainwright analyst Joseph Pantginis raised the price target on Armata Pharmaceuticals (NYSE: ARMP) to $9.00 (from $7.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login